May 2014, Vol 3, No 3

← Back to Issue

The Full Spectrum of Knowledge Driving Personalized Medicine

Darren Sigal, MD

Letter to Our Readers

Dear Colleague,

One of the fascinating aspects of personalized medicine is the recognition of how each component relates to all other components. Take this month’s “The Last Word” column, where one of healthcare’s premier policy authorities, Kip Piper, weighs in on the impact of the Affordable Care Act on cancer care in this second of a 2-part series. This leads us to reflect on the practical reality of healthcare’s triad of medical, business, and policy forces, intertwined and influencing the process of care. The editors of Personalized Medicine in Oncology (PMO) make certain to bring the whole picture of this process to practicing oncologists:

  • The clinical needs driving drug and device utilization
  • The business and policy context influencing clinical practice
  • The winners and losers in the wake of healthcare reform
  • Clarity of treatment options in a healthcare system undergoing a paradigm shift

Knowledge is power, and PMO is dedicated to increasing oncologists’ power to heal in this changing paradigm. The extraordinary variety of knowledge we organize for our readers helps bridge the gap from drug discovery to real-world practice. We are pleased to have you in our reading community as we open the door to the full spectrum of knowledge driving personalized medicine in cancer.

Sincerely,

Darren Sigal, MD
Scripps Clinic
PMO Board Member

Interview with the Innovators - May 15, 2014

Perspectives on the Landscape of Personalized Medicine

An Interview with Gail E. Herman, MD, PhD; Barbara L. McAneny, MD; and Charles L. Sawyers, MD

Gail E. Herman, MD, PhD, is President of the American College of Medical Genetics and Genomics (ACMG).Barbara L. McAneny, MD, is Chief Executive Officer of New Mexico Cancer Center, New Mexico Oncology Hematology Consultants, Ltd.Charles L. Sawyers, MD, is Chair of the Human Oncology & Pathogenesis Program at Memorial Sloan [ Read More ]

Uncategorized - May 16, 2014

The Affordable Care Act and Cancer Patients – Winners and Losers in an Unsteady Paradigm Shift: Part 2 The Conclusion of an Analysis of the ACA by Kip Piper, MA, FACHE

In the April issue of PMO, Mr Kip Piper, a leading healthcare policy authority, addressed the benefits of the Affordable Care Act (ACA) for cancer patients and oncologists. In this second report, he addresses the problems the ACA presents. For the ACA’s sword does indeed cut both ways, particularly in [ Read More ]